MedTrace Logo

High-flow Nasal Cannula vs. Helmet PSV vs. Helmet CPAP During Respiratory Failure

NCT04241861 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-02-08

No results posted yet for this study

Summary

The investigators designed a cross-over, randomized trial to assess the physiological effects of helmet pressure support ventilation (PSV) and continuous positive airway pressure (CPAP) as compared to high-flow nasal cannula during the early phase of acute hypoxemic respiratory failure

Conditions

Interventions

OTHER

Respiratory support (High-flow oxygen therapy)

Noninvasive respiratory support respiratory support

OTHER

Respiratory support (Helmet PSV)

Noninvasive respiratory support respiratory support

OTHER

Respiratory support (Helmet CPAP)

Noninvasive respiratory support respiratory support

Sponsors & Collaborators

  • Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Massimo Antonelli, MD · Fondazione Policlinico Universitario A. Gemelli, IRCCS

  • Domenico L Grieco, MD · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-22
Primary Completion
2021-01-27
Completion
2021-01-27

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04241861 on ClinicalTrials.gov